Barentz International, a prominent global distributor specializing in life science and specialty performance ingredients, has recently inked a significant distribution agreement with Ashland, Inc. This agreement will encompass Ashland's comprehensive portfolio of pharmaceutical and nutraceutical products, effective from November 1, 2023. The covered regions include Ireland, United Kingdom, Denmark, Sweden, Norway, Finland, Iceland, Estonia, Latvia, and Lithuania.
Barentz already serves as the distributor for Ashland's pharmaceutical and nutraceutical offerings in Belgium, The Netherlands, Poland, Slovakia, and the Czech Republic, further solidifying their longstanding partnership.
To ensure a seamless transition, Ashland will collaborate closely with the previous distributor to migrate customers to Barentz by the effective date of November 1. For further inquiries regarding Ashland's products and services in the covered regions, please contact: info.desk@barentz.com.